Associate Director, FP&A Portfolio Analysis at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Expertise in financial planning, budgeting, forecasting, and variance analysis for R&D portfolios
Proficiency with planning systems (Anaplan, Hyperion) and tools (SAP, Excel, Power BI)
Strong collaboration and business partnering skills with cross-functional teams (e.g., Therapeutic Area Finance Leads, R&D Portfolio teams, Hyderabad FP&A Hub)
Knowledge of internal controls, US GAAP, accounting standards, and corporate policies
Ability to synthesize insights, prepare executive presentations, and ensure data integrity and timely deliverables
Experience in process improvement, automation, standardization, and digital solutions (dashboards, data visualization)

Responsibilities

Lead development of annual budgets, quarterly forecasts, and long-range financial plans for R&D Portfolio spend (grants, supplies, alliances), aligning with strategic priorities
Own month-end and quarterly close narratives, variance analysis; consolidate financials across therapeutic areas and prepare materials for senior leadership
Deliver timely reporting to R&D leadership, assist in senior leader presentations, and govern high-quality submissions in planning systems
Track and analyze actuals vs. plan, identify variance drivers, spending trends, and provide insights on R&D Portfolio financial health
Collaborate with Therapeutic Area Finance Leads, R&D Portfolio Finance, Portfolio Strategy and Operations, BI&T, and Hyderabad FP&A Hub for cohesive planning and decision support
Champion process simplification, standardization, automation, and digital enhancements (dashboards, modeling) to reduce cycle time and improve decisions
Ensure compliance with internal controls, accounting standards, corporate policies; partner to standardize guidelines and fulfill US GAAP requirements

Skills

FP&A

Portfolio Planning

Financial Forecasting

Budgeting

Variance Analysis

Anaplan

Hyperion

Month-End Close

R&D Finance

Business Partnering

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free